EV Biologics Statistics

Total Valuation

EV Biologics has a market cap or net worth of 3.02 million.

Market Cap	3.02M
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

EV Biologics has 10.23 million shares outstanding.

Shares Outstanding	10.23M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.08
PB Ratio	0.02
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.11, with a Debt / Equity ratio of 15.32.

Current Ratio	3.11
Quick Ratio	0.80
Debt / Equity	15.32
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	0.27

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -82.34% in the last 52 weeks. The beta is -1.14, so EV Biologics's price volatility has been lower than the market average.

Beta (5Y)	-1.14
52-Week Price Change	-82.34%
50-Day Moving Average	0.88
200-Day Moving Average	0.84
Relative Strength Index (RSI)	32.69
Average Volume (20 Days)	2,057

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.01

Income Statement

In the last 12 months, EV Biologics had revenue of 9.47 million and -551,581 in losses. Loss per share was -0.23.

Revenue	9.47M
Gross Profit	1.54M
Operating Income	154,858
Pretax Income	-523,987
Net Income	-551,581
EBITDA	n/a
EBIT	154,858
Loss Per Share	-0.23

Full Income Statement

Balance Sheet

The company has 12.40 million in cash and 6.47 million in debt, giving a net cash position of 5.94 million or 0.58 per share.

Cash & Cash Equivalents	12.40M
Total Debt	6.47M
Net Cash	5.94M
Net Cash Per Share	0.58
Equity (Book Value)	42.23M
Book Value Per Share	17.52
Working Capital	35.33M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 16.24%, with operating and profit margins of 1.63% and -5.82%.

Gross Margin	16.24%
Operating Margin	1.63%
Pretax Margin	-5.53%
Profit Margin	-5.82%
EBITDA Margin	n/a
EBIT Margin	1.63%
FCF Margin	n/a

Dividends & Yields

EV Biologics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.68%
Shareholder Yield	-0.68%
Earnings Yield	-77.60%
FCF Yield	n/a

Stock Splits

The last stock split was on November 9, 2017. It was a reverse split with a ratio of 0.2.

Last Split Date	Nov 9, 2017
Split Type	Reverse
Split Ratio	0.2

Scores

EV Biologics has an Altman Z-Score of 1.58. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.58
Piotroski F-Score	n/a